UY33787A - Dosificaciones de derivados de arilsulfonamida - Google Patents

Dosificaciones de derivados de arilsulfonamida

Info

Publication number
UY33787A
UY33787A UY0001033787A UY33787A UY33787A UY 33787 A UY33787 A UY 33787A UY 0001033787 A UY0001033787 A UY 0001033787A UY 33787 A UY33787 A UY 33787A UY 33787 A UY33787 A UY 33787A
Authority
UY
Uruguay
Prior art keywords
derivatives
arilsulfonamide
dosage
directed
therapeutic use
Prior art date
Application number
UY0001033787A
Other languages
English (en)
Inventor
Combal Jean-Philippe
Elisabeth Latour
Original Assignee
Fovea Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fovea Pharmaceuticals filed Critical Fovea Pharmaceuticals
Publication of UY33787A publication Critical patent/UY33787A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La invención se dirige al uso terapéutico de derivados de arilsulfonamida.
UY0001033787A 2010-12-09 2011-12-09 Dosificaciones de derivados de arilsulfonamida UY33787A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10306382 2010-12-09

Publications (1)

Publication Number Publication Date
UY33787A true UY33787A (es) 2012-04-30

Family

ID=43628466

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001033787A UY33787A (es) 2010-12-09 2011-12-09 Dosificaciones de derivados de arilsulfonamida

Country Status (14)

Country Link
US (1) US20130253027A1 (es)
EP (1) EP2648713A1 (es)
JP (1) JP2014505030A (es)
CN (1) CN103402508A (es)
AR (1) AR084193A1 (es)
AU (1) AU2011340493A1 (es)
BR (1) BR112013014456A2 (es)
CA (1) CA2819951A1 (es)
MX (1) MX2013006526A (es)
RU (1) RU2013131280A (es)
TW (1) TW201231044A (es)
UY (1) UY33787A (es)
WO (1) WO2012076684A1 (es)
ZA (1) ZA201304079B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR084194A1 (es) * 2010-12-09 2013-04-24 Fovea Pharmaceuticals Derivados de arilsulfonamida para la prevencion o el tratamiento de trastornos oftalmologicos especificos

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2840897B1 (fr) * 2002-06-14 2004-09-10 Fournier Lab Sa Nouveaux derives d'arylsulfonamides et leur utilisation en therapeutique

Also Published As

Publication number Publication date
RU2013131280A (ru) 2015-01-20
EP2648713A1 (en) 2013-10-16
CN103402508A (zh) 2013-11-20
ZA201304079B (en) 2014-08-27
US20130253027A1 (en) 2013-09-26
JP2014505030A (ja) 2014-02-27
TW201231044A (en) 2012-08-01
AR084193A1 (es) 2013-04-24
BR112013014456A2 (pt) 2016-09-13
CA2819951A1 (en) 2012-06-14
MX2013006526A (es) 2014-06-11
WO2012076684A8 (en) 2013-07-18
WO2012076684A1 (en) 2012-06-14
AU2011340493A1 (en) 2013-05-02

Similar Documents

Publication Publication Date Title
UY34350A (es) Derivados de pirazolquinolinona, su preparación y su uso terapéutico.
CR20130045A (es) Compuestos terapéuticos
EA201300730A1 (ru) Производные индазолилтриазола
UA108101C2 (xx) Похідні n3-заміщених n1-сульфоніл-5-фторпіримідинонів
EA201270257A1 (ru) Производные n1-сульфонил-5-фторпиримидинона
EA201270254A1 (ru) Производные 5-фторпиримидинона
CR20130001A (es) Derivados de indolizina, su procedimiento de preparación y su aplicación en terapéutica
EA201591004A1 (ru) Производные бороновой кислоты и их терапевтическое применение
CL2013000016A1 (es) Compuestos derivados de imidazopiridina; procedimiento de preparacion; composicion farmaceutica y su uso en el tratamiento del cancer.
EA201270722A1 (ru) Формы рифаксимина и их применение
EA201270619A1 (ru) Применение бетанехола для лечения ксеростомии
EA201390929A1 (ru) Антитела к pcsk9 и способы их применения
BR112012019529A2 (pt) inibidores de d-nitrosoglutationa redutase
SMT201200017B (it) Nuovi antagonisti P2X7R e il loro uso.
UY34314A (es) Derivados de anilina, su preparación y su aplicación terapéutica.
EA201300034A1 (ru) Фармацевтические композиции, содержащие иматиниб или его фармацевтически приемлемую соль, и способы их получения
UY35747A (es) Derivados sustituidos de fenilalanina
EA201270253A1 (ru) Производные n1-ацил-5-фторпиримидинона
EA201291211A1 (ru) Фармацевтические композиции, содержащие гидроморфон и налоксон
DOP2013000241A (es) Derivados de 2-amino-3-(imidazol-2-il)-piridin-4-ona, preparación de los mismos y uso terapéutico de los mismos
DOP2012000260A (es) Uso de nuevos inhibidores de pan–cdk para tratar tumores
UY35745A (es) Derivados sustituidos de fenilalanina
EA201101195A1 (ru) Производные розувастатина и аторвастатина
SMT201600301B (it) USO TERAPEUTICO DELLA PROTEINAß2- MICROGLOBULINA
CR20150159A (es) Derivados oxazolidinona 3,4-disustituidos y su uso como inhibidores de potasio calcio activado